Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

amerisourcebergen

AmerisourceBergen acquires sterile compounder PharMEDium for $2.5bn

October 7, 2015 Research and Development, Sales and Marketing AmerisourceBergen, mergers and acquisitions

AmerisourceBergen will now source compounded drugs for its hospital clients by manufacturing them itself after spending more than $2.5 billion …
News
akabia_logo

Akebia passes vadadustat for anaemia phase III study with FDA & EMA

October 7, 2015 Research and Development Akabia, FDA, anaemia

Akebia Therapeutics has announced the successful completion of the End-of-Phase II Meeting process with the FDA and the Scientific Advice …
News
joachim_hoeltz

Rondo AG appoints Joachim Hoeltz as chief exec

October 7, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Joachim Hoeltz has been appointed chief executive at pharmaceutical packaging company Rondo AG within the Business Area Medipak Systems. He …
Appointment
merckincweb

NICE approves Merck’s Keytruda for advanced skin cancer following ipilimumab treatment

October 7, 2015 Research and Development Merck, NHS, NICE, keytruda, skin cancer

The National Institute for Health and Care Excellence (NICE) has approved Merck’s Keytruda (pembrolizumab) for treating advanced skin cancer after …
News
aubagio

Sanofi MS treatment Aubagio slows brain atrophy in Phase III trial

October 7, 2015 Research and Development Genzyme, MS, Sanofi

Sanofi and its subsidiary Genzyme have announced that magnetic resonance imaging (MRI) data from the Phase III TEMSO study demonstrate …
News
aristada

FDA approves Alkermes schizophrenia treatment

October 6, 2015 Research and Development Alkermes, Aristada, FDA, schizophrenia

The US Food and Drug Administration (FDA) has approved Alkermes’s Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia. Aristada …
News
flu_vaccien_smaller

Flu jab reduces risk of stroke for two months

October 6, 2015 Research and Development flu vaccine, stroke

The risk of suffering a stroke is significantly reduced for up to two months after receiving a flu vaccine, a …
News
oral_insulin

Moving forward in diabetes

October 6, 2015 Research and Development Novo Nordiak, diabetes

As many as 387 million people worldwide are living with diabetes, and it is predicted that by 2035 more than …
Feature
turing_logo

After Daraprim, Turing Pharma submits first in-house candidate to FDA

October 6, 2015 Manufacturing and Production, Research and Development turing

Turing Pharma may have been on the end of some less-than-favourable media coverage in recent weeks, but the company is …
News
teva

Teva acquires Mexico’s Rimsa for $2.3 billion

October 5, 2015 Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions

Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
News
medcity_bojo

Why London is at the heart of life sciences

October 5, 2015 Research and Development NHS

by Eliot ForsterWhatever disease you’re trying to cure, you can bet that somebody in London has it. That probably isn’t …
Feature
keytruda

FDA approves Merck’s Keytruda for advanced NSC lung cancer

October 5, 2015 Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo

The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …
News

Woodley Equipment to Attend Global Site Solutions Summit, Florida, USA

October 2, 2015 Manufacturing and Production, Research and Development woodley equipment

Woodley Equipment will attend the upcoming Global Site Solutions Summit in Florida, USAThe Global Site Solutions Summit is taking place …
News
Press release
stephen_gough

Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist

October 2, 2015 Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough

Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …
Appointment
genzyme_logo

Genzyme opts into Alnylam’s Thrombosis program

October 2, 2015 Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia

Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026